Nasal high-flow therapy (NHF) may be an alternative option for hypercapnic COPD patients who cannot tolerate the ‘gold standard’ of non-invasive ventilation (NIV), a study from New Zealand suggests. In a single blind comparison of NHF and NIV in 24 patients with hypercapnic respiratory failure secondary to COPD, respiratory physicians at the Medical Research Institute ...
NHF therapy a more tolerable alternative to NIV for hypercapnic COPD
By Michael Woodhead
14 May 2019